AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Albeglime M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Albert David Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Albeglime M 2mg/500mg Tablet

Diabetic patients using Glimel M (2mg/500mg), a dual-action antidiabetic medication, should adhere to their prescribed dosage and timing for optimal blood sugar management. This combination therapy, administered with meals for best absorption, requires consistent use even with seemingly controlled glucose levels. Discontinuation without medical consultation risks serious complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Maintaining a healthy diet, regular physical activity, and weight management, as directed by your physician, are essential components of your overall diabetes care plan. Commonly reported side effects include hypoglycemia (characterized by sweating, dizziness, headache, and tremors), necessitating regular meals and readily available glucose sources. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, gastrointestinal upset (nausea, diarrhea, abdominal pain), headache, upper respiratory infections, and weight gain. Glimel M is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Patients with a history of heart disease, or those who are pregnant or breastfeeding, should consult their doctor prior to initiating treatment. Regular blood glucose monitoring and periodic blood tests to assess hematologic parameters and liver function are recommended during treatment.

Uses of Albeglime M 2mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Albeglime M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Albeglime M 2mg/500mg tablets should be administered with a meal.

Common Side effects of Albeglime M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Albeglime M 2mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Albeglime M 2mg/500mg tablets should be administered with a meal.

How Albeglime M 2mg/500mg Tablet works:

Albeglime M 2mg/500mg tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Albeglime M 2mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Albeglime M 2mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

The medication Albeglime M 2mg/500mg Tablet is contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Albeglime M 2mg/500mg tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Albeglime M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Albeglime M 2mg/500mg Tablet :

Should you forget to take your Albeglime M 2mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Albeglime M 2mg/500mg Tablet

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Albeglime M 2mg/500mg Tablet

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Albeglime M 2mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may include muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Albeglime M 2mg/500mg Tablet use and seek immediate medical attention.
The tablet Albeglime M, containing 2mg glimepiride and 500mg metformin, treats type 2 diabetes mellitus in adults. This dual-action medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas to reduce blood glucose, while metformin decreases hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Taking Albeglime M 2mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headaches. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Albeglime M 2mg/500mg tablets may induce vitamin B12 deficiency with prolonged use due to impaired intestinal vitamin B12 absorption. Untreated deficiency can lead to anemia, neurological complications such as peripheral neuropathy (manifesting as paresthesia in the extremities), weakness, urinary dysfunction, cognitive changes, and ataxia. Prophylactic supplemental vitamin B12, at least annually, is recommended by some studies to mitigate these risks.
Albeglime M 2mg/500mg tablets can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar may include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol concurrently with Albeglime M 2mg/500mg tablets is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Albeglime M 2mg/500mg Tab...
144
MRP 175
17% off